The Dispatch(TM) catheter as a delivery tool for arterial gene transfer

Cardiovascular Research

Volumn 33, Issue 1, 1997, Pages 181-187

  Tahlil, Ouafae ^a   Brami, Marc ^a   Feldman, Laurent J ^a   Branellec, Didier ^b   Steg, Ph Gabriel ^a,c  

^a Faculté Xavier Bichat   (France)

^b SANOFI   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

gene expression; gene therapy; gene transfer; rabbit; restenosis

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATHETER; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; ENDOTHELIUM; GENE THERAPY; GENE TRANSFER; HISTOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RADIOGRAPHY; TECHNIQUE; ANIMAL; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; HUMAN ADENOVIRUS; ILIAC ARTERY; INDWELLING CATHETER; INSTRUMENTATION; LIVER; METHODOLOGY; PATHOLOGY; TRANSGENE; VASCULAR SMOOTH MUSCLE;

ADENOVIRUSES, HUMAN; ANIMALS; CATHETERS, INDWELLING; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; ILIAC ARTERY; LIVER; MALE; MUSCLE, SMOOTH, VASCULAR; RABBITS; TRANSFECTION; TRANSGENES;

EID: 0030615014     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00188-5     Document Type: Article

References (38)

1. Isner JM, Feldman LJ. Gene therapy for arterial disease. Lancet. 344:1994;1653-1654.
2. Lemarchand P, Jones M, Yamada I, Crystal RG. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Ciculation Research. 72:1993;1132-1138.
3. Morishita R, Gibbons GH, Kaneda Y, Ogihara T, Dzau VJ. Novel and effective gene transfer technique for study of vascular renin angiotensin system. J Clin Invest. 91:1993;2580-2585.
4. Nabel EJ, Plautz G, Boyce DM, Stanley JC, Nabel GJ. Recombinant gene expression in vivo within endothlial cells of the arterial wall. Science. 244:1989;1342-1344.
5. Steg PG, Feldman LJ, Scoazec JY, et al. Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector. Circulation. 90:1994;1648-1656.
6. Rome JJ, Shayani V, Flugelman MY, et al. Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscler Thromb. 14:1994;148-161.
7. Willard JE, Landau C, Glamann DB, et al. Genetic modification of the vessel wall. Comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus. Circulation. 89:1994;2190-2197.
8. Wolinsky H, Thung SN. Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J Am Coll Cardiol. 15:1990;475-481.
9. Feldman LJ, Steg PG, Zheng LP, et al. Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J Clin Invest. 95:1995;2662-2671.
10. Pastore C, Feldman LJ, Pericaudet M, et al. Intraluminal delivery of pluronic gel enhances adenovirus-mediated arterial gene transfer: a morphometric study. Circulation 1994;90:I-517(Abstract).
11. Pastore C, Feldman LJ, Pericaudet M, et al. Intraluminal delivery of pluronic gel enhances adenovirus-mediated arterial gene transfer: a morphometric study. Circulation 1994;90:I-517(Abstract).
12. Mitchel JF, Fram DB, Palme DF, et al. Enhanced intracoronary thrombolysis with urokinase using a novel, local drug delivery system. In vitro, in vivo, and clinical studies. Circulation. 91:1995;785-793.
13. Quantin B, Stratford-Perricaudet LD, Tajbakhsh S, Mandel J-L. Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA. 89:1992;2581-2584.
14. Rosenfield MA, Yochimura K, Trapnell BC, et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell. 68:1992;143-155.
15. Bonnerot C, Rocancourt D, Briand P, Grimber G, Nicolas J-F. A β galactosidase hybrid protein targeted to nuclei as a marker for developmental studies. Proc Natl Acad Sci USA. 84:1987;6795-6799.
16. Lynch CM, Clowes MM, Osborne WRA, Clowes AW, Miller AD. Long-term expression of human adenosine deaminase in vascular smooth muscle cells of rats: a model for gene therapy. Proc Natl Acad Sci USA. 89:1992;1138-1142.
17. Lee SW, Trapnell BC, Rade JJ, Virmani R, Dichek DA. In vivo adenoviral vector-medited gene transfer into balloon-injured rat carotid arteries. Circ Res. 73:1993;797-807.
18. Chang MW, Barr E, Lu M, Barton K, Leiden JM. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin invest. 96:1995;2260-2268.
19. French BA, Mazur W, Ali N, et al. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. Circulation. 90:1994;2402-2413.
20. Wolinsky H, Lin C-S. Use of the perforated balloon catheter to infuse marker substances into diseased coronary artery walls after experimental postmortem angioplasty. J Am Coll Cardiol. 17:1991;174B-178B.
21. Tahlil O, Branellec D, Aubailly N, et al. Reduction of restenosis after angioplasty by gene therapy with HSV-tk and ganciclovir. Results from a double injury model in the hypercholesterolemic rabbit. Circulation 1995;92:I-295(Abstract).
22. Tahlil O, Branellec D, Aubailly N, et al. Reduction of restenosis after angioplasty by gene therapy with HSV-tk and ganciclovir. Results from a double injury model in the hypercholesterolemic rabbit. Circulation 1995;92:I-295(Abstract).
23. Groh WC, Kurnik PB, Matthai WH, Untereker WJ. Initial experience with an intracoronary flow support device providing localized drug infusion: The scimed dispatch catheter. Cath Cardiovasc Diagn. 36:1995;67-73.
24. Camenzind E, Kint P-P, di Mario C, et al. Intracoronary heparin delivery in humans: acute feasibility and long-term results. Circulation. 92:1995;2463-2472.
25. Camenzind E, di Mario C, de Jaegere P, et al. Left ventricular and coronary hemodynamics during local drug delivery with a new infusion catheter: first experience in humans. Eur Heart J 1994;15(abstr suppl):561(Abstract).
26. Cascells W, Willerson JT. Amphotropic but not atherotropic: another caveat for adenoviral gene therapy. J Clin Invest. 95:1995;2425-2426.
27. Chang MW, Barr E, Seltzer J, et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science. 267:1995;518-522.
28. Shi Y, Pieniek M, Fard A, et al. Adventitial remodelling after coronary arterial injury. Circulation. 93:1996;340-348.
29. Losordo DW, Pickening JG, Takeshita S, et al. Use of the rabbit ear artery to serially assess foreign protein secretion after site specific arterial gene transfert in vivo. Circulation. 89:1994;785-792.
30. Ohno T, Gordon D, San H, et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science. 265:1994;781-784.
31. Guzman RJ, Lemarchand P, Crystal RG, Epstein SE, Finkel T. Efficient and selective adenovirus-mediated gene transfer into vascular neointima. Circulation. 88:1993;2838-2848.
32. Schneider MD, French BA. The advent of adenovirus: gene therapy for cardiovascular disease. Circulation. 88:1993;1937-1942.
33. March KL, Gradus-Pizlo I, Wilensky RL, Yei S, Trapnell BC. Cardiovascular gene therapy using adenoviral vectors: distant transduction following local delivery using a porous balloon catheter. J Am Coll Cardiol. 23:1994;177A. Abstract.
34. Wilensky RL. The problems and the promise of local drug delivery. Restenosis Summit VI 1994;352-355.
35. Wilensky RL. The problems and the promise of local drug delivery. Restenosis Summit VI 199
36. March KL, Yei S, Madison J, Trapnell BC. Vascular smooth muscle-directed adenoviral vectors. J Am Coll Cardiol 1995;366A(Abstract).
37. March KL, Yei S, Madison J, Trapnell BC. Vascular smooth muscle-directed adenoviral vectors. J Am Coll Cardiol 1995;366A(Abstract).
38. Harats D, Kurihara H, Belloni P, et al. Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter. J Clin Invest. 95:1995;1335-1344.